Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-05-000022
Filing Date
2005-01-21
Accepted
2005-01-21 17:20:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUARY 21, 2005 oncolytics13ga-012105.txt SC 13G/A 7965
  Complete submission text file 0001013594-05-000022.txt   9320
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Subject) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-77907 | Film No.: 05542415
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ONE AMERICAN LANE GREENWICH CT 06831 2036258300
AMARANTH LLC (Filed by) CIK: 0001167129 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A